echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JAMA Sub-Journal: Carbamazepine vs. Lamotrigine, who is "better" in treating epilepsy?

    JAMA Sub-Journal: Carbamazepine vs. Lamotrigine, who is "better" in treating epilepsy?

    • Last Update: 2022-01-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    It is only for medical professionals to read and refer to clinical information.
    As China gradually enters an aging society, stroke is a common disease of the nervous system, the incidence rate is increasing year by year, and post-stroke epilepsy (PSE) is a complication of stroke.
    Also increased [1]
    .

    Post-stroke epilepsy refers to the absence of a history of epileptic seizures before the stroke, but multiple seizures after the stroke, which are confirmed to be caused by the stroke
    .

    In addition to cerebral aneurysms, arteriovenous malformations, etc.
    , which should be treated with corresponding etiologies, the current post-stroke epilepsy is mainly treated with antiepileptic drugs [2]
    .

    Source: Screenshot of the literature.
    Recently, Larsson D and others published a paper on JAMA Neurol in the Journal of the American Medical Association-Neurology.
    The project compared the survival rate of patients with epilepsy after stroke with different anti-epileptic drugs.
    [3]
    .

    Let's take a look at today's newsletter! Want to see more previous issues of "Top Journal Essentials"? Go to the "Clinical Assistant in the Medical Field" service account to have a look! 1.
    Click on the business card below to follow the official account of "Clinical Assistant in the Medical Field" 2.
    Find the "Top Journal Essentials" in the menu bar 3.
    View the latest journals in each subject area 4.
    You can also click on "Subscription Settings" 5.
    Subscribe to the subject area you follow Subscribe to the daily push of the subject and read a new top issue every day! Let's use such an easy-to-use tool! References: [1].
    Xu Fei, Jin Ping, Wang Yu.
    Analysis of related risk factors for epileptic seizures after stroke[J].
    Chinese Journal of Disease Control,2017,21(02):179-182.
    [2].
    Huang Yuangui .
    Stroke and Epilepsy[J].
    Chinese Journal of Cardiovascular and Cerebrovascular Diseases in the Elderly,2013,15(05):449-451.
    [3].
    Larsson D, Baftiu A, Johannessen Landmark C, von Euler M, Kumlien E, Åsberg S, Zelano J.
    Association Between Antiseizure Drug Monotherapy and Mortality for Patients With Poststroke Epilepsy.
    JAMA Neurol.
    2021 Dec 13.
    doi: 10.
    1001/jamaneurol.
    2021.
    4584.
    Epub ahead of print.
    PMID: 34902006.
    Source of this article: Clinical Assistant Responsibility in the Medical Community Editor: Xiaodangdang Sun Ying's medical community strives for the accuracy and reliability of its published content at the time of review, but does not make any promises and guarantees on the timeliness of the published content, as well as the accuracy and completeness of the cited information (if any), etc.
    , And does not assume any responsibility due to the outdated content and the possible inaccuracy or incompleteness of the cited information
    .

    Relevant parties are requested to check separately when adopting or using this as a basis for decision-making
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.